Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure

Circulation

Volumn 100, Issue 24, 1999, Pages 2443-2448

  Chen, Horng H ^a   Schirger, John A ^a   Chau, William L ^a   Jougasaki, Michihisa ^a   Lisy, Ondrej ^a   Redfield, Margaret M ^a   Barclay, Paul T ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Kidney; Metalloprotease; Natriuretic peptides; Neurohormones; Ventricles

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CANDOXATRILAT; CYCLIC GMP; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION;

EID: 0032805710     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.24.2443     Document Type: Article

References (32)

1. Volpe M, Rao MAE, Tritto C, Pisani A, Mele AF, Enea I, Condorelli M. Transition from asymptomatic left ventricular dysfunction to congestive heart failure. J Card Failure 1995;1:409-419.
2. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang C, Kubo SH, SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
3. Brandt RB, Wright RS, Redfield MM, Burnett JC Jr. Atrial natriuretic peptide in heart failure. J Am Coll Cardiol. 1993;22:86A-92A.
4. Stevens TL, Burnett JC Jr, Kinoshita M, Matsuda Y, Redfield M. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest. 1995;95:1101-1108.
5. Margulies KB, Cavero PG, Seymour AA, Delaney NG, Burnett JC Jr. Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int. 1990;38:67-72.
6. Abassi ZA, Haramati A, Hoffman A, Burnett JC Jr, Winaver J. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol. 1990;259:R84-R89.
7. Kenny AJ, Stephenson SL. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett. 1988;232:1-8.
8. Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG, Burnett JC Jr. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation. 1990;82:196-201.
9. Lipkin GW, Dawnay ABS, Harwood SM, Cattall WR, Raine REG. Enhanced natriuretic response to neutral endopeptidase inhibition in patients with moderate chronic renal failure. Kidney Int. 1997;52: 792-801.
10. Wilkins MR, Settle SL, Stockmann PT, Needleman P. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci U S A. 1990;87:6465-6469.
11. Smits GJ, McGraw DE, Trapani AJ, Blaine EB. Effect of endopeptidase 24.11 inhibition in conscious cardiomyopathic hamsters. J Pharmacol Exp Ther. 1990;254:176-179.
12. Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG, Burnett JC Jr. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation. 1990;82:196-201.
13. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;327:685-691.
14. Redfield MM, Aarhus LL, Wright RS, Burnett JCJ. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation. 1993;87:2016-2022.
15. Margulies KB, Perrella MA, McKinley LJ, Burnett JC Jr. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. J Clin Invest. 1991;88: 1636-1642.
16. Chan DP, Sandok EK, Aarhus LL, Heublein DM, Burnett JC Jr. Renal specific actions of angiotensin II receptor antagonism in the anesthetized dog. Am J Hypertens. 1992;5:354-360.
17. Burnett JC Jr, Hu DC, Heser D. Atrial natriuretic peptide elevation in congestive heart failure in man. Science. 1986;231:1145-1146.
18. Steiner AL, Parker CW, Kipnis DM. Radioimmunoassay for cyclic nucleotidase. J Biol Chem. 1972;247:1106-1113.
19. Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969;29:1349-1355.
20. Sando J, Haber E. A direct microassay for aldosterone in plasma extracts. J Clin Endocrinol Metab. 1978;47:391-396.
21. Kimmelstiel CD, Perrone R, Kilcoyne L, Souhrada J, Udelson J, Smith J, de Bold A, Griffith J, Konstam MA. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure. Cardiology. 1996;87:46-53.
22. Trippodo NC, Gabel RA, Harvey CM, Asaad MM, Rogers WL. Heart failure augments the cardiovascular and renal effects of neutral endopeptidase inhibition in rats. J Cardiovasc Pharmacol. 1991;18:308-316.
23. Margulies KB, Heublein DM, Burnett JC Jr. ANF-mediated renal cyclic GMP generation in congestive heart failure. Am J Physiol. 1991;260: F562-F568.
24. Ura N, Carretero OA, Erdos E. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int. 1987;32:507-513.
25. Margulies KB, Burnett JC Jr. Atrial natriuretic factor modulates whole kidney tubuloglomerular feedback. Am J Physiol. 1990;259:R97-R101.
26. Mitchell KD, Navar G. Enhanced tubuloglomerular feedback during peritubular infusion of angiotensin I and II. Am J Physiol. 1988;255: F383-F390.
27. Dussaule JC, Stefanski A, Bea ML, Ronoco P, Ardaillou R. Characterization of neutral endopeptidase in vascular smooth muscle cell of rabbit renal cortex. Am J Physiol. 1993;264:F45-F52.
28. Sonnenberg H, Honrath U, Wilson DR. In vivo microperfusion of inner medullary collecting duct in rats: effect of amiloride and ANF. Am J Physiol. 1990;259:F222-F226.
29. Salazar FJ, Granger JP, Fiksen-Olsen MJ, Bentley MD, Romero JC. Possible modulatory role of angiotensin II on atrial peptide-induced natriuresis. Am J Physiol. 1987;253:F883.
30. Showalter CJ, Zimmerman RS, Schwab TR, Edwards BS, Opgenorth TJ, Burnett JC Jr. Renal response to atrial natriuretic factor is modulated by intrarenal angiotensin II. Am J Physiol. 1988;254:R453-R456.
31. Smith JB, Lincoln TM. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol. 1987;253: C147-C150.
32. SHEP Cooperative Research Group. Prevention of heart failure by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1997;278:212-216.